论文信息 - ABT-869 a Multi-Targeted Receptor Tyrosine Kinase Inhibitor: Inhibition of FLT3 Phosphorylation and Signaling in Acute Myeloid Leukemia Running Title: ABT-869 Receptor Tyrosine Kinase Inhibitor in AML - 字舞流文

ABT-869 a Multi-Targeted Receptor Tyrosine Kinase Inhibitor: Inhibition of FLT3 Phosphorylation and Signaling in Acute Myeloid Leukemia Running Title: ABT-869 Receptor Tyrosine Kinase Inhibitor in AML

K. Glaser | S. Davidsen | Eric F. Johnson | N. Soni | M. Michaelides | K. Sakamoto | D. Shankar | Jun Guo | P. Tapang | D. Albert | R. Wei | N. Shah | P. Marcotte | Yujia Dai | J. Bouska | Junling Li | L. Pease | Kresna Hartandi | Donald J. Osterling | T. Moore | K. Rhodes | S. Priceman | J. McCall | H. Daniel | Jenny Chang | K. Albert